This panel examines how sustained commitment to research, innovation and health system modernisation can accelerate the development and deployment of next-generation therapies across Europe. It also looks at how public policy, private investment and multi-stakeholder collaboration can improve patient outcomes while supporting a thriving life sciences ecosystem.
Panellists include:
Rainer Becker, Director of Medical Products & Innovation, DG SANTE, European Commission
Vytenis Andriukaitis MEP, Biotech Act Rapporteur for SANT Committee, European Parliament, and former European Commissioner for Health & Food Safety
Claire Skentelbery, Director General, EuropaBio
Avril Daly, President of EURORDIS - Rare Diseases Europe
Muiris O’Connor, Assistant Secretary at Department of Health, Head of Research & Development and Health Analytics.
Podden och tillhörande omslagsbild på den här sidan tillhör
IIEA. Innehållet i podden är skapat av IIEA och inte av,
eller tillsammans med, Poddtoppen.
